surmount-1 week 12 weight loss tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial Weight reduction with different doses
Pay in 4 interest-free payments of $6.80 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8













:max_bytes(150000):strip_icc()/insulin-injection-478185779-594b3cae3df78cae8111498f.jpg)








